
Pharmaceuticals • Biotechnology • Healthcare Insurance
Madrigal Pharmaceuticals is a biopharmaceutical company focused on developing novel therapeutics for nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). The company achieved a significant milestone with the accelerated FDA approval of its first therapy for adults with NASH with moderate to advanced liver fibrosis. Madrigal is actively conducting a Phase 3 trial for the treatment of NASH with compensated cirrhosis. The company is dedicated to improving care for patients with NASH/MASH through its ambitious research programs and therapeutic developments.
51 - 200 employees
💊 Pharmaceuticals
🧬 Biotechnology
⚕️ Healthcare Insurance
💰 $259M Post-IPO Equity on 2022-12
November 21
Quality Assurance Specialist ensuring compliance with cGMP processes and supporting quality event management at Madrigal Pharmaceuticals. Collaborating with cross-functional teams for effective investigations and quality metrics tracking.
🔔 Pennsylvania – Remote
💵 $87k - $107k / year
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🟡 Mid-level
🟠 Senior
🔧 QA Engineer (Quality Assurance)
🦅 H1B Visa Sponsor
November 21
Associate Director focusing on Global Health Economics & Outcomes Research for Madrigal's liver disease treatments. Leading real-world evidence projects to drive patient access and optimal pricing.
🍂 Massachusetts – Remote
💵 $179k - $219k / year
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
October 28
Associate Director of Medical Writing at Madrigal Pharmaceuticals. Ensuring the accuracy and quality of clinical documents for liver disease therapies.
🍂 Massachusetts – Remote
💵 $173k - $211k / year
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🟠 Senior
✏️ Content Writer
🦅 H1B Visa Sponsor
August 21
Associate Director of Medical Writing leads Phase 1–IV clinical documents for NASH programs; collaborates across teams to ensure regulatory-compliant, high-quality documents.
🍂 Massachusetts – Remote
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🟠 Senior
✏️ Content Writer
🦅 H1B Visa Sponsor
March 18
Oversee GCP quality assurance activities for clinical trials at Madrigal, a biopharmaceutical company.
🇺🇸 United States – Remote
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🟡 Mid-level
🟠 Senior
🔧 QA Engineer (Quality Assurance)
🦅 H1B Visa Sponsor
Google Cloud Platform
February 22
Madrigal Pharmaceuticals seeks a Director of Medical Writing to guide clinical and regulatory documents for NASH treatments.
🇺🇸 United States – Remote
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🔴 Lead
✏️ Content Writer
🦅 H1B Visa Sponsor
February 22
Lead medical writing efforts for clinical trials at Madrigal focusing on NASH therapies.
🇺🇸 United States – Remote
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🔴 Lead
✏️ Content Writer
🦅 H1B Visa Sponsor
February 14
Associate Director of MSAT leads technical strategy for large-scale manufacturing with a cross-functional team at Madrigal.
🇺🇸 United States – Remote
💰 $259M Post-IPO Equity on 2022-12
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor